Open access peer-reviewed chapter

The Threat of Methicillin Resistant Staphylococcus aureus (MRSA) in the Aquatic Environment via Wastewater Generated from Healthcare Facilities

Written By

Abimbola Olumide Adekanmbi, Ridwan Olamilekan Adesola, Adedoyin Olutoyin Adeyemi and Chisom Chinyere Mbionwu

Submitted: 18 September 2023 Reviewed: 20 November 2023 Published: 20 December 2023

DOI: 10.5772/intechopen.113967

From the Annual Volume

Bacterial Infectious Diseases Annual Volume 2023

Edited by Katarzyna Garbacz and Tomas Jarzembowski

Chapter metrics overview

61 Chapter Downloads

View Full Metrics

Abstract

In most developing countries of the world and few advanced ones, wastewater are discharged into the environment without any form of treatment, thus exposing the general public to hazardous chemicals, residual antibiotics, heavy metals and so many antimicrobial compounds. This chapter deals with the threat posed by methicillin resistant Staphylococcus aureus (MRSA) introduced into the aquatic ecosystem via wastewater generated from the operations of healthcare facilities. It focuses more on the microbiology and composition of wastewater from the hospital environment, and the role they played as a stimulant for the development of resistance in bacteria, while also emphasizing their roles as important reservoirs of MRSA in the aquatic environment. The epidemiology of MRSA in wastewater discharge from low-middle and high -income countries was examined, with another dig at the public health significance of these organisms in the water environment. The concluding part dwells heavily on the management and control strategies from the authors’ perspective, and this includes the one-health approach and the enactment of Government policies to control the indiscriminate discharge of untreated wastewater from the healthcare settings into receiving water bodies.

Keywords

  • wastewater
  • hospital wastewater (HWW)
  • healthcare facilities
  • methicillin resistant Staphylococcus aureus (MRSA)
  • aquatic environment

1. Introduction

Wastewater is any water whose quality has been lowered as a result of anthropogenic influence, and could be from several sources including agricultural, domestic, pharmaceutical, and hospitals. Wastewater from the hospital environment comes from various places hence the composition could vary. These places include the surgical areas, administrative blocks, laundries, laboratories, wards and the kitchens [1]. These wastewater contain a lot of hazardous and potentially dangerous chemicals compared to the urban wastewater. Most of these compounds are persistent and potentially toxic and could include radionuclides, disinfectants, antiseptics, quaternary ammonium compounds (QAC), solvents, remnants of drugs, and some antimicrobial compounds at various concentrations [2, 3, 4]. Verlicchi et al. [5] in a review, reported that the concentrations of antibiotics, analgesics and metals (micro-pollutants) in HWW are between 4 and 150 times higher than in urban wastewater, making HWW a hub of several toxic agents. In addition to this, hospital wastewater (HWW) is also a repository of antibiotic resistant organisms and resistance genes, as reported in a study by Adekanmbi et al. [6] on the diversity of resistant Escherichia coli and their genes in wastewater of a University Health care center. Wastewater and other receiving water bodies receiving input of HWW are pre disposed to pathogenic organisms, making them a threat to the existence of aquatic organisms and also the health of the human population. In this chapter, we try to explore the threat posed to the aquatic environment via the release of methicillin resistant Staphylococcus aureus and proffer some solutions in curbing the menace.

Advertisement

2. Wastewater from healthcare systems (composition and microbiology)

Wastewater is any water from different processing and manufacturing operations such as pharmaceuticals, agriculture, domestic sources, and healthcare centres, whose quality have been tainted by a high level of anthropogenic influence [7]. The hospital wastewater is however quite different from wastewater from other sources because it contains a vast number of micro- and macro- pollutants, which have been discharged from the different departments of hospitals including laboratories, theaters, laundries, research units and other notable sections [8]. Most of the pollutants in questions range from pharmaceuticals, chemical compounds, metals, media remnants, antibiotics, disinfectants, radioactive isotopes, and stock cultures [9]. In some instances, some pharmaceuticals present in hospital wastewater have been implicated in causing the disruption of the endocrine system, impairment of the reproductive system and sex reversal in some aquatic species [10]. The discharge of this wastewater has led to the build-up of nutrients in the receiving aquatic ecosystem, leading to eutrophication [7].

In many countries of the world, wastewater from the healthcare settings are discharged into sewage channels without any form of pre-treatment, after which it undergoes treatment in the municipal wastewater treatment plants, but in most instances, the treatment is not sufficient to remove these pollutants from the wastewater [11]. Another worrisome situation is the fact that pharmaceutical compounds present in the wastewater could undergo transformation and form conjugates, whose toxicity could be higher than that of the parent metabolite [12].

The HWW can act as an ideal medium for the proliferation of various classes of microorganisms e.g. viruses, bacteria, fungi and other parasites. Wastewater generated from the operations of the healthcare facilities is also a hub of bacteria showing resistance to several classes of antibiotics and antibiotic residues, which could cause an inhibition of the sensitive bacteria, thereby causing an elevation of the population of the resistance bacteria in the receiving water channels. These resistant bacteria could also act as vectors for the transmission of genes, or serve as vehicles and reservoirs for the proliferation of antibiotic resistance genes (ARG), that could pose a potential threat to public health [13].

HWW poses a very challenging threat to humans, society, hospital employees, patients, public health and the environment at large, as it has been implicated in the spread of infective diseases, and could also be a vehicle in terms of contagiousness [14]. A very worrisome constituent of HWW are the residual drugs. When medications are consumed by patients, the drugs are not fully metabolized by the human body, and residual concentrations are excreted into sewage or other receiving water sources via urine and feces. These residual quantities of these antimicrobial compounds act as stimulants for the onset of resistance in the microflora of the water or wastewater, thus leading to an increase in the population of potentially pathogenic strains of organisms [15]. These pathogenic organisms, which could be viruses, bacteria, algae, yeasts, protozoa, parasites and sometimes bacteriophages could survive for a long time in the receiving soils or water, and could eventually find their way into the food chain, causing infectious diseases and so many health risks to humans [16].

2.1 Wastewater from the healthcare facilities: a stimulant for antibiotic resistance

The treatment procedures for wastewater do not completely remove antibiotics, which increases the amount of antibiotics in aquatic ecosystems [17, 18]. The observed amounts of many antibiotics in surface water range from 0.001 to 484 g/L globally [19]. According to studies, the use of antibiotics in aquatic environments is linked to an increase in the number of antibiotic resistant bacteria (ARB) and the emergence of resistance genes [20]. Horizontal gene transfer (HGT) and mutagenesis in bacteria are influenced to a large extent by sub-inhibitory doses/concentration of antibiotics in aquatic systems [21]. As a result, a number of pathogenic microorganisms have developed resistance to the most potent medicines, and it is unclear how quickly new antibiotic resistant microorganisms emerge. Antibiotic resistant microorganisms disseminate resistance genes in the environment and transmit them to the following generation [22].

Clinical sewages have long served as important sources of antibiotic resistance determinants in aquatic ecosystems due to the usage of antibiotics in hospitals, particularly due to the excretion of their powerful forms into the environment [23]. Previous research revealed that HWW contains significant amounts of microorganisms and antibiotic drug residues, which has the ability to exert selective pressure on the spread of antibiotic resistant bacteria [24]. Consequently, compared to other wastewater systems, such as urban sewage systems, HWW is likely to pose greater hazards of the spread of ARGs [25, 26]. Therefore, hospitals and other healthcare settings are considered as one of the leading polluting sectors around the world [27]. Hospital wastewater treatment facilities in particular are regarded and best defined as the epicenter and major location for the spread of antibiotic resistance that could endanger public health if water is reused [28, 29].

Large amounts of antibiotics and other substances can impose selective pressure at low concentrations (below therapeutic levels) in pharmaceutical wastewaters from pharmaceuticals and healthcare wastewater [30, 31]. Studies have demonstrated that wastewaters produced during the manufacture of pharmaceuticals are reservoirs of antibiotic resistant bacteria (ARB) and antibiotic resistance genes (ARGs), and they may hasten the potential horizontal transfer of environmental resistance determinants across the endogenous microbial community [30, 32, 33].

Antibiotic-resistant bacteria (ARB) and their functional metabolites, as well as resistance genes (ARG), are frequent and pervasive pollutants in many ecosystems as a result of years of antibiotic misuse and overuse [34, 35]. Excreta from people and animals, as well as wastewater, are acknowledged and documented as primary sources of the microorganisms and chemicals mentioned above [34]. Despite the fact that treatment methods can lower pathogen concentrations in wastewater, wastewater treatment plant effluents do not generally show a significant reduction of ARB and ARG, and a lot of these pathogens, possibly from hospitals, are released into the recipient waterways [28, 36].

According to recent reports, the environment contains other key sources of antibiotic resistance, such as animal farms, wastewater treatment facilities [WWTPs] [32, 37, 38]. Since antibiotic resistance genes are now regarded as environmental contaminants, it is evident that their future dissemination must be prevented [39, 40]. To enable this, it is necessary to clarify their potential reservoirs, particularly those found in the environment. A major global public health concern is the prevalence of antibiotic resistance genes (ARGs) in the environment due to the extensive use of antibiotics in healthcare systems, agriculture, and breeding [41, 42]. Long-term trends show that the use of antibiotics is increasing, thus stagnation or decline is not anticipate [43]. To prevent the establishment of resistance, research is already pointing to the potential use of novel medications in combination with nanotechnologies. Different nanomaterials having antibacterial properties based on carbon, titanium, silver, or gold are used in several new technologies [44].

In low- and middle-income countries (LMIC), where many hospitals either lack wastewater treatment plants or have inadequate ones, the hazards of such clinical illnesses may be more serious. To make matters worse, surface water is frequently used for home and agricultural uses, or even ingested untreated, especially in rural regions [23]. Antibiotic resistance genes are disseminated in such waters and have been reported to be more widespread in environmental non-pathogenic microbial populations than was originally believed [45, 46]. According to reports, these resistances spread among bacterial populations in two main ways: vertical gene transfer (during bacterial cell division) and horizontal gene transfer, or conjugation, transformation, and transduction, supported by mobile genetic elements (MGEs) [47]. The diversity, distribution, and future of ARGs in urban water systems are still unknown, despite the fact that antibiotic resistance is widely acknowledged as a major danger to human public health [48].

Regulations on sludge/sewage emission criteria have been adopted globally since the 1980s in an effort to reduce the harm caused by effluent after it is discharged [49]. However, only a few countries (such as France and Italy) have set up laws governing hospital wastewater (HWW) treatment before release [50]. Unfortunately, no emission standard for wastewater has required the biological safety assessment of ARGs [51]. The current condition results in a significant biosafety risk of ARGs from HWW, which has been largely disregarded by legislation and contemporary wastewater treatment facilities [51].

2.2 Wastewater from healthcare facilities: a reservoir for the introduction of MRSA into the aquatic ecosystem

Hospital wastewater poses a significantly greater environmental threat than urban effluent [52]. The hospitals use an enormous quantity of water each day, ranging from 400 to 1200 liters, and produce a sizeable amount of wastewater each day in their operations [53]. These facilities are also renowned for the wide range and high rates of wastewater pollution in aquatic environments [54]. Hospitals are well known for their excessive and ongoing usage of antibiotics [55]. According to Bui et al. [56], between 30 and 90% of antibiotics are not absorbed by the human body; and as a result, they are discharged directly into effluent and build up in wastewater treatment systems. A significant global concern shared by many scientific researchers is the possibility that bacteria could come into contact with antibiotics and develop antibiotic resistance due to this situation [57]. To develop efficient solutions to stop the emergence and spread of this issue, a worldwide strategy is necessary.

Most antibiotics used are excreted into wastewater, where they may sustain or impose selective pressure on microorganisms culminating in resistance development [58]. In wastewater, antibiotic resistant bacteria and genes are frequently found in more significant numbers and concentrations than in surface water [59]. Additionally, wastewater can foster the development of a diverse bacterial community that serves as a breeding ground for bacteria that are resistant to antibiotics. As a result, it has been hypothesized that wastewater treatment facilities contribute to the spread and evolution of antibiotic-resistant microorganisms. Methicillin-resistant Staphylococcus aureus (MRSA) is a significant issue globally as a nosocomial pathogen. Still, less is known about its incidence in non-clinical settings, such as wastewater, and what role wastewater has in spreading and developing MRSA in aquatic ecosystems. Staphylococcus aureus is a bacterial pathogen linked to various human infections, such as skin infections, pneumonia, and septicemia [60]. Due to the strains’ frequent resistance to one or more antibiotics, particularly methicillin, infections caused by these bacteria can be challenging to cure. Since its discovery in 1960, infections caused by methicillin-resistant S. aureus (MRSA) have predominantly been linked to hospital settings and are called hospital-acquired MRSA [61]. MRSA, just like extended spectrum β-lactamase (ESBL)-producing Enterobacterales, has historically been a cause of nosocomial infections, but is now becoming common place even in non-clinical settings [62]. On top of that, MRSA can be found in wastewater from sewage treatment facilities (STPs) [63]. Staphylococcus aureus, including MRSA, has been the subject of numerous surveys in Europe and the United States as an indicator bacterium in wastewater and river water [64].

2.3 Epidemiology of MRSA in wastewater from healthcare facilities in low-middle- and high-income countries

Antimicrobial-resistant bacteria are increasingly causing environmental water pollution issues on a global scale [65]. In addition to making antibiotic treatment challenging, the appearance and spread of Antimicrobial-resistant bacteria have become a significant issue for hospitals and other healthcare facilities [66]. This is because it increases the danger of epidemics and severe outbreaks of infectious illnesses. The World Health Organization (WHO) released a list of 12 particular groups of antimicrobial resistant bacteria (AMRB). Methicillin-resistant Staphylococcus aureus (MRSA) is listed as a high-priority bacterium among these AMRB, following carbapenem-resistant Acinetobacter baumannii, carbapenem-resistant Pseudomonas aeruginosa, and carbapenem-resistant/third generation cephalosporin-resistant Enterobacterales that are listed as critical priorities [67]. One of the most significant aspects of the epidemiology of MRSA is the global onset and dissemination of the disease caused by these pathogens. As seen in Table 1, many countries have reported the spread of all MRSA subtypes. MRSA is one of the most common nosocomial pathogens currently and is known to be more prevalent in hospital settings. The Centre for Disease Control and Prevention (CDC) reported that MRSA is a serious concern to public health due to its rising frequency in hospitals, the general population, and animals, as well as its transmission between people and animals, infection rates, resistance, and therapeutic challenges [77].

Year of studyPrevalenceSourceCountriesRegionReference
202294–96%Hospital effluent and Healthcare facility effluentJapanHigh-income country[67]
202197%Hospital effluentJapanHigh-income country[68]
201370–81%Regional hospital and Metropolitan hospitalAustraliaHigh-income country[69]
2019 to 202037.5%Hospital wastewaterJapanHigh-income country[70]
201210%Hospital wastewaterEthiopiaLow-income country[71]
2020100%Hospital wastewaterBangladeshLow-middle-income country[72]
201590%Hospital effluentIndiaLow-middle-income country[73]
201711%, and 8%Raw and Treated hospital sewage waterIranLow-middle-income country[74]
2019 to 202046.9%Hospital wastewaterPortugalHigh-income country[75]
201547%Hospital wastewaterIranLow-middle-income country[76]
201553%Hospital wastewaterIranLow-middle-income country[76]

Table 1.

Prevalence of MRSA in wastewater from healthcare facilities from different countries.

2.4 Public health challenges of MRSA in the aquatic environment

The ubiquitous bacteria- Staphylococcus aureus - causes a wide range of infections, from minor skin infections to serious and potentially fatal invasive diseases [78]. The bacterium could invade the skin, mucosal membranes, and internal organs and cause severe sickness in both humans and animals, including septicemia, osteomyelitis, endocarditis, respiratory tract infection, and suppurative infections of the skin [79]. Additionally, S. aureus is one of the main causes of mastitis in cattle [80]. The environment of hospitals and the humans are both well suited to Staphylococcus aureus. It is a major factor in endocarditis, bacteremia, osteomyelitis, and infections of the skin and soft tissues. S. aureus swiftly became a major cause of infections related to health care as hospital-based medicine took off [81].

The treatment of bacterial illnesses relies heavily on antibiotics. As the number of bacteria that are resistant to antibiotics increases, there are less and fewer drugs that can effectively combat certain infections. Bacteria develop resistance mostly by horizontal gene transfer and genetic alterations, which allow infections to flourish in the environment while antibiotics are present [82, 83]. Hospitals and other settings are increasingly encountering multiple drug resistant strains, causing hazardous illnesses for people [84].

Within the next 30 years, the world’s population is expected to reach 10 billion, and agricultural production is expected to rise by 70%. This will further put pressure on freshwater supplies [85]. Nearly 50% of the world’s population use contaminated water sources to irrigate crops, and it is estimated that 20 million hectares are watered with wastewater [86]. Many cities throughout the world with historically low rainwater collection have used wastewater in agriculture for generations. It is also becoming a more important alternative source of water in nations mostly affected by water scarcity, particularly in those that depend on agriculture for a living. Re-using untreated wastewater is one of the few accessible options to the sophisticated procedures used in the majority of wastewater treatment facilities in high-income nations for many low-income countries [87]. High levels of pathogens, pharmaceuticals, heavy metals, plastic additives, and other contaminants can be found in wastewater, and these contaminants might negatively affect plant growth when wastewater is used for their irrigation [88].

Pharmaceuticals, personal care items, antibiotic residues, antimicrobial resistant bacteria (ARB), and antimicrobial resistance genes (ARGs) are contaminants of particular concern [89]. Antibiotics have been detected in treated wastewater effluent and ARB/ARGs can withstand or even proliferate at treatment plants [90, 91]. Wastewater irrigation can result in ongoing antibiotic exposure for the irrigated crops, which can cause the establishment of resistant bacteria. ARGs can be transferred between native soil communities and wastewater bacteria via irrigation-delivered ARB in wastewater [92].

The following vegetables can be eaten raw: carrot, radish, cucumber, tomato, cabbage, lettuce, coriander, and. Food-borne illnesses could occasionally develop from improper washing and peeling, which can act as a vehicle for several germs. Numerous microorganisms can infect people through the oral route [93]. For instance, since lettuce is not processed before consumption, all of the (resistant) bacteria that are present in it may be directly ingested by consumers [94]. Because they are necessary components of our diet and are frequently eaten raw or with minimal preparation, fruits and vegetables can be a major source of human pathogens [95]. Market garden items are frequently thought to be contaminated by irrigation water [96]. The fact that they come from market gardeners who have already engaged in self-medication by treating infections brought on by their working tools, can explain the presence of multidrug resistant Staphylococcus aureus [97].

Surface waters have been noted as possible antibiotic and antibiotic resistance reservoirs [98, 99]. In numerous countries, research have found genes and pathogens associated with antibiotic resistance in lakes, rivers, streams, ponds, and estuaries. A possible risk of human exposure to resistant bacteria exists since some of the surface waters that contain antimicrobial resistance genes (ARGs) are used for recreational purposes [100]. Antibiotic residues, heavy metals, natural processes, and climate change are the causes of antibiotic resistance in surface waterways, whereas healthcare facilities, wastewater, agricultural settings, food, and wildlife populations are the main vehicles [101, 102]. For hospitals and other medical facilities, the formation and spread of antimicrobial resistance has become a critical issue since it makes antimicrobial treatment challenging and raises the danger of epidemics and severe outbreaks of infectious illnesses [103].

Penicillin provided temporary relief, but in the 1940s, resistance developed through the β-lactamase gene blaZ. Around 1960, the first semi-synthetic anti-staphylococcal penicillins were created, and within a year after its initial clinical application, methicillin-resistant S. aureus (MRSA) was discovered [81]. Since an emergence of these strains has been noted, the World Health Organization (WHO) now recognizes MRSA as a high-priority pathogen [104].

Resistance to methicillin and oxacillin is caused by the acquisition of a gene that encodes a PBP2 homolog termed PBP2a that is resistant to drug activity [105106]. The peptidoglycan produced when an MRSA strain is cultured in the presence of β-lactams is not well cross-linked. If the MRSA strain is exposed to β-lactams, one outcome of this is that the peptidoglycan has higher proinflammatory effects, which may lead to pathology during infection [107]. The mecA gene, which is part of a family of various but connected staphylococcal chromosomal cassette (SCC) elements, encodes PBP2a [105, 108] while MecC, a unique PBP2a with just 63% residue identity to MecA, was recently found. In Europe, it mostly affects one lineage of MRSA [109]. Some MRSA strains have spread across the globe, while others are endemic to specific geographic areas [110]. In the original MRSA strains, drug exposure is the causative factor for the mecA gene to be expressed. MecIR regulatory proteins, which are related to the BlaIR proteins that govern blaZ expression, are in charge of it [105, 106].

Antibiotic-resistant S. aureus has also been isolated from municipal water supplies both domestically and internationally [111, 112], in the hospital [69], and agricultural wastewaters/sewage [112, 113], depicting potential sources of contamination of the human environment. According to estimates, 1.8 billion people, mostly in underdeveloped nations, drink contaminated water [114]. Humans are exposed to contaminated surface water as a result of contaminated rivers and lakes’ role in the release, mixing, and persistence of antibiotic-resistant bacteria (ARB) and their antibiotic resistance genes (ARGs) [115].

2.5 Management and control strategies

The World Health Organization (WHO) has urged countries to create a Global Action Plan on Antimicrobial Resistance, a framework for an action plan for AMRB, and has argued that comprehensive measures should be taken to assess and resolve the issues involving AMRB, taking into account their interactions among people, animals, and the environment based on the fundamental principle of One Health [116]. These countermeasures include Clarification of the pollution status and an evaluation of the environmental danger of MRSA in aquatic environments: For life to exist, there must be water. Additionally, more medicines and residues are discovered in the ambient compartment. Water pollution is one of the critical issues associated with water, along with water scarcity and floods. Drug residues and resistant microbes can be found in large quantities in hospital wastewater, but the situation is much more severe in numerous countries. In LMIC, where drug use is more prevalent, the Sustainable Development Goals are critical [117]. However, according to the United Nations [102], over 80% of the world’s wastewater is dispersed into the environment without sufficient treatment. Water recycling is likely necessary to address water shortages and advance a circular economy, but the quality of the recycled water must be ensured. As part of the Registration, Evaluation, Authorization, and Restriction of Chemicals Program (ECREARCP) of the European Commission, ecotoxicological evaluations based on bioaccumulation tests are crucial for determining the environmental risk of chemical compounds. In order to assess the risk that prospective water pollutants pose and, consequently, whether specific restrictions should be imposed, the Surface Water “Watch List” under the Water Framework Directive (WFD) is a system used in Europe. For the benefit of other regions of the world, especially the LMIC, this list should be updated every 2 years and made available.

2.5.1 Surveillance

As part of the hospital infection control program, surveillance must be conducted regularly and a recognized component of the clinical governance process. For bench-marking purposes, surveillance data should be gathered and published consistently, using agreed-upon case definitions and specialty activity denominators, with case mix stratification. Most hospital staff should easily understand surveillance data, which should be discussed often at hospital senior management committees and in regional infection control training. The results of microbiological tests conducted for clinical purposes, as well as the results of those investigations conducted for screening purposes, should all contain MRSA monitoring if there are any requirements in the hospital state rules.

2.5.2 Screening

MRSA carriage should be actively screened for in hospital wastewater and patient samples, and the findings should be connected to a focused strategy for isolation and facility cohorts. It is essential to routinely check hospital wastewater that poses a high MRSA risk. The infection control team must conduct local screening of the hospital wastewater, discuss it with the necessary clinical teams, and receive approval from the pertinent hospital management structure. This will affect the risk status of each hospital wastewater, the local prevalence of MRSA in the wastewater, and the propensity for MRSA to be present in the wastewater.

2.5.3 Antibiotic stewardship

Many hospital staff members need to be made aware of antibiotics’ use and side effects. Identifying key personnel in charge of monitoring antibiotic resistance and consumption, prescriber education, and the effects of antibiotics in wastewater on aquatic life and the community are critical elements of implementing antibiotic stewardship programs in healthcare facilities. The prevalence of MRSA in hospital wastewater can be decreased by avoiding inappropriate or excessive antibiotic therapy and prophylaxis, making sure that antibiotics are administered at the correct dosage and for the right amount of time, and only the proper antibiotics in cases of infection.

2.5.4 One health approach

One Health Approach is founded on the idea that treating each issue separately will prevent us from understanding the interconnectedness of human, animal, and environmental health. We need a comprehensive approach to grasp these domains’ interdependence to tackle complicated public health concerns. However, what impact would One Health have on our healthcare system? The community’s dynamic microbiological inputs from people and animals are included in hospitals as incubators. The use of antibiotics places selection pressure on these incoming microbial populations, causing a change to a more significant proportion of resistant organisms. Hospital-associated multidrug-resistant organisms (MDRO) can colonize people while they are in the hospital (both patients and staff). A feedback loop is initiated when they are released back into the community. The hospital serves as a surveillance site and a multiplier for resistant organisms and infections due to MDRO acquisition and infection, which further emphasizes the need to describe community- and hospital-based risk factors that affect the hospital environment. By considering the interaction between the patient, the hospital equipment, the hospital environment, and the role of the community, a One Health approach may help create unique research and multi-modal intervention approaches. This includes well-known local risk factors for MRSA colonization in hospital wastewater, such as patients, pet ownership, or residing in an area with an active livestock industry. The complexity of hospital infection control warrants a multidisciplinary approach. An integrated approach is required to direct research avenues and public policy mediation.

Advertisement

3. Conclusion

This write-up further outlines the public health challenge associated with the discharge of untreated wastewater from healthcare facilities into the environment. This act not only introduce potentially pathogenic microorganisms into the environment, it also serve as a medium for the dissemination of the antibiotic resistant strains of which MRSA is a major threat. There is an urgent need to put mitigation protocols in place to prevent a potential public health breakdown as a result of the unwholesome act of discharging wastewater into receiving water bodies and the environment at large without any form of treatment. Relevant agencies in countries affected by this menace should wake up to their responsibilities and carry out enlightenment campaigns to educate hospitals and the populace on the danger inherent in such practices. A stitch in time saves nine.

Advertisement

Acknowledgments

The authors would like to appreciate the authors whose work served as the reference point for this chapter.

Advertisement

Conflict of interest

The authors declare no conflict of interest.

References

  1. 1. Fekadu S, Merid Y, Beyene H, Teshome W, Gebre-Selassie S. Assessment of antibiotic- and disinfectant- resistant bacteria in hospital wastewater, South Ethiopia: A cross-sectional study. Journal of Infection in Developing Countries. 2015;9(2):149-156
  2. 2. Chonova T, Keck F, Labanowski J, Montuelle B, Rimet F, Bouchez A. Separate treatment of hospital and urban wastewaters: A real scale comparison of effluents and their effect on microbial communities. Science of The Total Environment. 2016;542:965-975
  3. 3. Santos LH, Gros M, Rodriguez-Mozaz S, Delerue-Matos C, Pena A, Barcelo D, et al. Contribution of hospital effluents to the load of pharmaceuticals in urban waste-waters: Identification of ecologically relevant pharmaceuticals. Science of The Total Environment. 2013;461-462:302-316
  4. 4. Verlicchi P, Al Aukidy M, Galletti A, Petrovic M, Barcelo D. Hospital effluent: Investigation of the concentrations and distribution of pharmaceuticals and environmental risk assessment. Science of The Total Environment. 2012;430:109-118
  5. 5. Verlicchi P, Galletti A, Petrovic M, Barcelo D. Hospital effluents as a source of emerging pollutants: An overview of micropollutants and sustainable treatment options. Journal of Hydrology. 2010;389:416-428
  6. 6. Adekanmbi AO, Soyoye OF, Adelowo OO. Characterization of methicillin-resistance gene mecA in coagulase negative staphylococci (CoNS) recovered from wastewater of two healthcare facilities in Nigeria. Gene Reports. 2019;17(1-5):100541
  7. 7. Buelow E, Bayjanov JR, Willems RJ, Bonten MJ, Schmitt H, Van Schaik W. The microbiome and resistome of hospital sewage during passage through the community sewer system. bioRxiv. 2017 (Unpublished)
  8. 8. Al-Enazi MS. Evaluation of wastewater discharge from Al-Sadr teaching hospital and its impact on the Al-Khorah channel and Shatt Al-Arab River in Basra City-Iraq. Evaluation. 2016;6(12):55-65
  9. 9. Ahsan N. Study of widely used treatment technologies for hospital wastewater and their comparative analysis. International Journal of Advanced Engineering Technology. 2012;5(1):227
  10. 10. Obasi AI, Amaeze NH, Osoko DD. Microbiological and toxicological assessment of pharmaceutical wastewater from the lagos megacity, Nigeria. Chinese Journal of Biology. 2014;2014:1-9
  11. 11. Vieno N. Occurrence of Pharmaceuticals in Finnish Sewage Treatment Plants, Surface Waters, and their Elimination in Drinking Water Treatment Processes. Finland: Tampere University of Technology; 2007
  12. 12. Tiwari B, Sellamuthu B, Ouarda Y, Drogui P, Tyagi RD, Buelna G. Review on fate and mechanism of removal of pharmaceutical pollutants from wastewater using biological approach. Bioresource Technology. 2017;1(12):224
  13. 13. Asfaw T, Negash L, Kahsay A, Weldu Y. Antibiotic resistant bacteria from treated and untreated hospital wastewater at Ayder referral hospital, Mekelle, North Ethiopia. Advances in Microbiology. 2017;7(12):871
  14. 14. Akin BS. Contaminant properties of hospital clinical laboratory wastewater: A physiochemical and microbiological assessment. Journal of Environmental Protection. 2016;7(05):635
  15. 15. Nunez L, Moretton J. Disinfectant-resistant bacteria in Buenos Aires city hospital wastewater. Brazilian Journal of Microbiology. 2007;38(4):644-648
  16. 16. Gurel M. A global overview of treated wastewater guidelines and standards for agricultural reuse. Fresenius Environmental Bulletin. 2007;16(6):590-595
  17. 17. Hiller CX, Hübner U, Fajnorova S, Schwartz T, Drewes JE. Antibiotic microbial resistance (AMR) removal efficiencies by conventional and advanced wastewater treatment processes: A review. Science of The Total Environment. 2019;685:596-608
  18. 18. Savin M, Bierbaum G, Hammerl JA, Heinemann C, Parcina M, Sib E, et al. Antibiotic-resistant bacteria and antimicrobial residues in wastewater and process water from German pig slaughterhouses and their receiving municipal wastewater treatment plants. Science of The Total Environment. 2020;727:13878
  19. 19. Danner MC, Robertson A, Behrends V, Reiss J. Antibiotic pollution in surface fresh waters: Occurrence and effects. Science of The Total Environment. 2019;664:793-804
  20. 20. Petrovich ML, Zilberman A, Kaplan A, Eliraz GR, Wang Y, Langenfeld K, et al. Microbial and viral communities and their antibiotic resistance genes throughout a hospital wastewater treatment system. Frontiers in Microbiology. 2020;11:153
  21. 21. Cabello FC, Godfrey HP, Tomova A, Ivanova L, Dölz H, Millanao A, et al. Antimicrobial use in aquaculture Re-examined: Its relevance to antimicrobial resistance and to animal and human health. Environmental Microbiology. 2013;15:1917-1942
  22. 22. Shallcross LJ, Howard SJ, Fowler T, Davies SC. Tackling the threat of antimicrobial resistance: From policy to sustainable action. Philosophical Transactions of the Royal Society B Biological Science. 2015;370:20140082
  23. 23. Lien LT, Lan PT, Chuc NT, Hoa NQ , Nhung PH, Thoa NT, et al. Antibiotic resistance and antibiotic resistance genes in Escherichia coli isolates from hospital wastewater in Vietnam. International Journal of Environmental Research and Public Health. 2017;14:699
  24. 24. Rowe WPM, Baker-Austin C, Verner-Jeffreys DW, Ryan JJ, Micallef C, Maskell DJ, et al. Overexpression of antibiotic resistance genes in hospital effluents over time. Journal of Antimicrobial Chemotherapy. 2017;72:1617-1623. DOI: 10.1093/jac/dkx017
  25. 25. Verlicchi P, Al Aukidy M, Zambello E. What have we learned from worldwide experiences on the management and treatment of hospital effluent? - An overview and a discussion on perspectives. Science of the Total Environment. 2015;514:467-491. DOI: 10.1016/j.scitotenv.2015.02.020
  26. 26. Zheng HS, Guo WQ , Wu QL, Ren NQ , Chang JS. Electro-peroxone pretreatment for enhanced simulated hospital wastewater treatment and antibiotic resistance genes reduction. Environment International. 2018;115:70-78. DOI: 10.1016/j.envint.2018.02.043
  27. 27. Achak M, Alaoui Bakri S, Chhiti Y, M’hamdi Alaoui FE, Barka N, Boumy W. SARS-CoV-2 in hospital wastewater during outbreak of COVID-19: A review on detection, survival and disinfection technologies. Science of the Total Environment. 2021;761:143192. DOI: 10.1016/j.scitotenv.2020.143192
  28. 28. Rizzo L, Manaia C, Merlin C, Schwartz T, Dagot C, Ploy MC, et al. Urban wastewater treatment plants as hotspots for antibiotic resistant bacteria and genes spread into the environment: A review. Science of the Total Environment. 2013;447:345-360. DOI: 10.1016/j. scitotenv. 2013.01.032
  29. 29. Yuan T, Pia Y. Hospital wastewater as hotspots for pathogenic microorganisms spread into aquatic environment: A review. Frontiers in Environmental Science. 2023;10:1734. DOI: 10.3389/fenvs.2022.1091734
  30. 30. Karkman A, Do TT, Walsh F, Virta MPJ. Antibiotic-resistance genes in wastewater-review. Trends in Microbiology. 2017;26:220-228
  31. 31. Lundborg CS, Tamhankar AJ. Antibiotic residues in the environment of South East Asia. British Medical Journal. 2017;358:j2440. DOI: 10.1136/bmj.j2440
  32. 32. Hultman J, Tamminen M, Parnanen K, Cairns J, Karkman A, Virta M. Host range of antibiotic resistance genes in wastewater treatment plant influent and effluent. FEMS Microbiology Ecology. 2018;94:fiy038
  33. 33. Obayiuwana AC, Ogunjobi A, Yang M, Ibekwe M. Characterization of bacterial communities and their antibiotic resistance profiles in wastewaters obtained from pharmaceutical facilities in Lagos and Ogun states, Nigeria. International Journal of Environmental Research and Public. 2018;15:1365-1378
  34. 34. Sobsey M, Abebe L, Andremont A, Ashbolt N, de Roda Husman AM, Gin K, et al. Briefing Note—Antimicrobial Resistance: An Emerging Water. Geneva, Switzerland: Sanitation and Hygiene Issue; WHO; 2014
  35. 35. Kraemer SA, Ramachandran A, Perron GG. Antibiotic pollution in the environment: From microbial ecology to public policy. Microorganisms. 2019;7:180
  36. 36. Leclercq R, Oberle K, Galopin S, Cattoir V, Budzinski H, Petit F. Changes in enterococcal populations and related antibiotic resistance along a medical center–wastewater treatment plant–river continuum. Applied and Environmental Microbiology. 2013;79:2428-2434
  37. 37. Ducey TF, Durso ML, Ibekwe AM, Dungan RS, Jackson CR, Frye JG, et al. A newly developed Escherichia coli isolate panel from across section of U.S. animal production systems reveals geographic and commodity-based differences in antibiotic resistance gene carriage. Journal of Hazardous Materials. 2020;382:120991
  38. 38. He Y, Yuan Q , Mathieu J, Stadler L, Senehi N, Sun R, et al. Antibiotic resistance genes from livestock waste: Occurrence, dissemination, and treatment. NPJ Clean Water. 2020;3:4
  39. 39. World Health Organization (WHO). Antimicrobial Resistance: Global Report on Surveillance. Geneva, Swizerland: WHO; 2014
  40. 40. Roca I, Akova M, Baquero F, Carlet J, Cavaleri M, Coenen S, et al. The global threat of antimicrobial resistance: Science for intervention. New Microbes and New Infections. 2015;6:22-29
  41. 41. Ju F, Li B, Ma L, Wang Y, Huang D, Zhang T. Antibiotic resistance genes and human bacterial pathogens: Co-occurrence, removal, and enrichment in municipal sewage sludge digesters. Water Research. 2016;91:1-10. DOI: 10.1016/j. watres. 2015.11.071
  42. 42. Ma L, Li AD, Yin XL, Zhang T. The prevalence of integrons as the carrier of antibiotic resistance genes in natural and man-made environments. Environmental Science and Technology. 2017;51:5721-5728. DOI: 10.1021/acs.est.6b05887.s001
  43. 43. Klein EY, Milkowska-Shibata M, Tseng KK, Sharland M, Gandra S, Pulcini C, et al. Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000-2015: An analysis of pharmaceutical sales data. The Lancet Infectious Diseases. 2021;21:107-115
  44. 44. Sánchez-López E, Gomes D, Esteruelas G, Bonilla L, Lopez-Machado AL, Galindo R, et al. Metal-based nanoparticles as antimicrobial agents: An overview. Nanomaterials. 2020;10:292
  45. 45. Nesme J, Cécillon S, Delmont TO, Monier JM, Vogel TM, Simonet P. Large-scale metagenomic-based study of antibiotic resistance in the environment. Current Biology. 2014;24:1096-1100
  46. 46. Surette MD, Wright GD. Lessons from the environmental antibiotic resistome. Annual Review of Microbiology. 2017;71:309-329
  47. 47. Khan S, Knapp CW, Beattie TK. Antibiotic resistant bacteria found in municipal drinking water. Environmental Processes. 2016;3:541-552
  48. 48. Munck C, Albertsen M, Telke A, Ellabaan M, Nielsen PH, Sommer MO. Limited dissemination of the wastewater treatment plant core resistome. Nature Communications. 2015;6:8452
  49. 49. Meng XZ, Venkatesan AK, Ni YL, Steele JC, Wu LL, Bignert A, et al. Organic contaminants in Chinese sewage sludge: A meta-analysis of the literature of the past 30 years. Environmental Science & Technology. 2016;50:5454-5466. DOI: 10.1021/acs.est.5b05583
  50. 50. Al Aukidy M, Al Chalabi S, Verlicchi P. Hospital wastewater treatments adopted in Asia, Africa, and Australia. In: Verlicchi P, editor. Hospital Wastewaters. Baghdad: Springer International Publishing AG; 2017. pp. 171-188
  51. 51. Guo WQ , Zheng HS, Li S, Du JS, Feng XC, Yin RL, et al. Removal of cephalosporin antibiotics 7-ACA from wastewater during the cultivation of lipid-accumulating microalgae. Bioresource Technology. 2016;221:284-290. DOI: 10.1016/j.biortech.2016.09.036
  52. 52. Kumari A, Maurya NS, Tiwari B. Hospital wastewater treatment scenario around the globe. Current Developments in Biotechnology and Bioengineering. 2020;2020:549-570
  53. 53. Majumder A, Gupta AK, Ghosal PS, Varma M. A review on hospital wastewater treatment: A particular emphasis on occurrence and removal of pharmaceutically active compounds, resistant microorganisms, and SARS-CoV-2. Journal of Environmental Chemical Engineering. 2021;9(2):104812
  54. 54. Ajo P, Preis S, Vornamo T, Mänttäri M, Kallioinen M, Louhi-Kultanen M. Hospital wastewater treatment with pilot-scale pulsed corona discharge to remove pharmaceutical residues. Journal of Environmental Chemical Engineering. 2018;6(2):1569-1577
  55. 55. Khan NA, Ahmed S, Farooqi IH, Ali I, Vambol V, Changani F, et al. Occurrence, sources and conventional treatment techniques for various antibiotics present in hospital wastewaters: A critical review. TrAC Trends in Analytical Chemistry. 2020;129:115921
  56. 56. Bui XT, Chen SS, Nguyen PD, Nguyen TT, Nguyen TB. Hospital wastewater treatment by sponge membrane bioreactor coupled with ozonation process. Chemosphere. 2019;230:377-383
  57. 57. Pepi M, Focardi S. Antibiotic resistant bacteria in aquaculture and climate change: A challenge for health in the Mediterranean area. International Journal of Environmental Research and Public Health. 2021;18(11):5723
  58. 58. Polianciuc SI, Gurzău AE, Kiss B, Ştefan MG, Loghin F. Antibiotics in the environment: Causes and consequences. Medicine and Pharmacy Reports. 2020;93(3):231-240
  59. 59. Börjesson S. Antibiotic Resistance in Wastewater: Methicillin-Resistant Staphylococcus aureus (MRSA) and Antibiotic Resistance Genes (Doctoral dissertation). Sweden: Linköping University Electronic Press; 2009
  60. 60. Ahmad-Mansour N, Loubet P, Pouget C, Dunyach-Remy C, Sotto A, Lavigne JP, et al. Staphylococcus aureus toxins: An update on their pathogenic properties and potential treatments. Toxins. 2021;13(10):677
  61. 61. Ayliffe GA. The progressive intercontinental spread of methicillin resistant Staphylococcus aureus. Clinical Infectious Diseases. 1997;24(Supplement_1):S74-S79
  62. 62. Pitout JD, Laupland KB. Extended-spectrum β-lactamase-producing Enterobacteriaceae: An emerging public-health concern. The Lancet Infectious Diseases. 2008;8(3):159-166
  63. 63. Rahimi F, Katouli M, Pourshafie MR. Characterization of methicillin resistant Staphylococcus aureus strains in sewage treatment plants in Tehran, Iran. Journal of Water and Health. 2021;19(2):216-228
  64. 64. Aires-de-Sousa M. Methicillin resistant Staphylococcus aureus among animals: Current overview. Clinical Microbiology and Infection. 2017;23(6):373-380
  65. 65. Vittecoq M, Godreuil S, Prugnolle F, Durand P, Brazier L, Renaud N, et al. Antimicrobial resistance in wildlife. Journal of Applied Ecology. 2016;53(2):519-529
  66. 66. Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: A global multifaceted phenomenon. Pathogens and Glob Health. 2015;109(7):309-318
  67. 67. Azuma T, Murakami M, Sonoda Y, Ozaki A, Hayashi T. Occurrence and quantitative microbial risk assessment of methicillin resistant Staphylococcus aureus (MRSA) in a sub-catchment of the Yodo River basin, Japan. Antibiotics (Basel). 2022;11(10):1355
  68. 68. Azuma T, Hayashi T. Effects of natural sunlight on antimicrobial resistant bacteria (AMRB) and antimicrobial-susceptible bacteria (AMSB) in wastewater and river water. Science of the Total Environment. 2021;766:142568
  69. 69. Thompson JM, Gündoğdu A, Stratton HM, Katouli M. Antibiotic resistant Staphylococcus aureus in hospital wastewaters and sewage treatment plants with special reference to methicillin-resistant Staphylococcus aureus (MRSA). Journal of Applied Microbiology. 2013;114(1):44-54
  70. 70. Nishiyama M, Praise S, Tsurumaki K, Baba H, Kanamori H, Watanabe T. Prevalence of antibiotic-resistant bacteria ESKAPE among healthy people estimated by monitoring of municipal wastewater. Antibiotics (Basel). 2021;10(5):495
  71. 71. Moges F, Endris M, Belyhun Y, Worku W. Isolation and characterization of multiple drug resistance bacterial pathogens from wastewater in hospital and non-hospital environments, Northwest Ethiopia. BMC Research Notes. 2014;7:1-6
  72. 72. Rahman MM, Devnath P, Jahan R, Talukder A. Detection of multiple antibiotic resistant bacteria from the hospital and non-hospital wastewater sources of a small town in Noakhali, Bangladesh. Journal of Applied Biology and Biotechnology. 2021;9(3):59-65
  73. 73. Mandal SM, Ghosh AK, Pati BR. Dissemination of antibiotic resistance in methicillin resistant Staphylococcus aureus and vancomycin resistant S. aureus strains isolated from hospital effluents. American Journal of Infection Control. 2015;43(12):e87-e88
  74. 74. Akya A, Chegenelorestani R, Shahvaisi-Zadeh J, Bozorgomid A. Antimicrobial resistance of Staphylococcus aureus isolated from hospital wastewater in Kermanshah, Iran. Risk Management and Healthcare Policy. 2020;13:1035-1042
  75. 75. Silva V, Ribeiro J, Rocha J, Manaia CM, Silva A, Pereira JE, et al. High frequency of the EMRSA-15 clone (ST22-MRSA-IV) in hospital wastewater. Microorganisms. 2022;10(1):147
  76. 76. Torabi M, Rahimi F. Characteristics of methicillin resistant Staphylococcus aureus strains isolated from hospital wastewater in Tehran, Iran. Infection Epidemiology and Microbiology. 2021;7(3):215-227
  77. 77. Dalton KR, Rock C, Carroll KC, Davis MF. One health in hospitals: How understanding the dynamics of people, animals, and the hospital built-environment can be used to better inform interventions for antimicrobial-resistant gram-positive infections. Antimicrobial Resistance and Infection Control. 2020;9(1):78
  78. 78. Kadariya J, Smith TC, Thapaliya D. Staphylococcus aureus and staphylococcal food-borne disease: An ongoing challenge in public health. BioMed Research International. 2014;2014:1-9. Article ID: 827965. DOI: 10.1155/2014/827965
  79. 79. Alaklobi F, Aljobair F, Alrashod A, et al. The prevalence of community-associated methicillin resistant Staphylococcus aureus among outpatient children in a tertiary hospital: A prospective observational study in Riyadh, Saudi Arabia. International Journal of Pediatrics and Adolescent Medicine. 2015;2:136-140. DOI: 10.1016/j. ijpam. 2015.09.001
  80. 80. Elsayed MS, Aem EB, Dawoud MA. Phenotypic and genotypic detection of virulence factors of Staphylococcus aureus isolated from clinical and subclinical mastitis in cattle and water buffaloes from different farms of Sadat City in Egypt. Veterinary World. 2015;8:1051. DOI: 10.14202/vetworld.2015.1051-1058
  81. 81. Harkins CP et al. Methicillin- resistant Staphylococcus aureus emerged long before the introduction of methicillin into clinical practice. Genome Biology. 2017;18:130
  82. 82. Nesme J, Simonet P. The soil resistome: A critical review on antibiotic resistance origins, ecology and dissemination potential in telluric bacteria. Environmental Microbiology. 2015;17:913-930
  83. 83. Timothy JF. Antibiotic resistance in Staphylococcus aureus. Current status and future prospects. FEMS Microbiology. 2017;41(3):430-449
  84. 84. Velasco V, Buyukcangaz E, Sherwood JS, Stepan RM, Koslofsky RJ, Logue CM. Characterization of Staphylococcus aureus from humans and a comparison with İsolates of animal origin, in North Dakota, United States. PLoS One. 2015;10(10):e0140497
  85. 85. Odegard IYR, Voet E. Van der the future of food-scenarios and the effect on natural resource use in agriculture in 2050. Ecological Economics. 2014;97:51-59
  86. 86. Bougnom BP, Thiele-Bruhn S, Ricci V, Zongo C, Piddock LJV. Raw wastewater irrigation for urban agriculture in three African cities increases the abundance of transferable antibiotic resistance genes in soil, including those encoding extended spectrum β-lactamases (ESBLs). Science of the Total Environment. 2020;698:134201
  87. 87. Saldias C, Speelman S, Huylenbroeck GV, Vink N. Understanding farmers’ preferences for wastewater reuse frameworks in agricultural irrigation: Lessons from a choice experiment in the western cape, South Africa. Water SA. 2016;42:26-37
  88. 88. Pop CE, Draga S, Măciucă R, Nit ă R, Crăciun N, Wolff R. Bisphenol A effects in aqueous environment on Lemna minor. Processes. 2021;9:1512
  89. 89. Liu JL, Wong MH. Pharmaceuticals and personal care products (PPCPs): A review on environmental contamination in China. Environment International. 2013;59:208-224
  90. 90. Gatica J, Cytryn E. Impact of treated wastewater irrigation on antibiotic resistance in the soil microbiome. Environmental Science and Pollution Research. 2013;20:3529-3538
  91. 91. Nnadozie CF, Kumari S, Bux F. Status of pathogens, antibiotic resistance genes and antibiotic residues in wastewater treatment systems. Reviews in Environmental Science and Biotechnology. 2017;16:491-515
  92. 92. Christou A, Agüera A, Bayona JM, Cytryn E, Fotopoulos V, Lambropoulou D, et al. The potential implications of reclaimed wastewater reuse for irrigation on the agricultural environment: The knowns and unknowns of the fate of antibiotics and antibiotic resistant bacteria and resistance genes—A review. Water Research. 2017;123:448-467
  93. 93. Amoah P, Drechsel P, Abaidoo RC, Klutse A. Effectiveness of common and improved sanitary washing methods in selected cities of West Africa for the reduction of coliform bacteria and helminth eggs on vegetables. Tropical Medicine & International Health. 2007;12:40-50
  94. 94. Holvoet K, Sampers I, Callens B, Dewulf J. Moderate prevalence of antimicrobial resistance in Escherichia coli isolates from lettuce, irrigation water, and soil. Applied and Environmental Microbiology. 2013;79:6677-6683
  95. 95. Bekele F, Tefera T, Biresaw G, Yohannes T. Parasitic contamination of raw vegetables and fruits collected from selected local markets in Arba Minch town, Southern Ethiopia. Infectious Diseases of Poverty. 2017;6:1-7
  96. 96. Rasheed MU, Thajuddin N, Ahamed P, Teklemariam Z, Jamil K. Resistência microbiana a drogas em linhagens de Escherichia coli isoladas de fontes alimentares. Revista do Instituto de Medicina Tropical de São Paulo. 2014;56:341-346
  97. 97. Moussé W, Sina H, Mama-Sirou IA, Anago E, Dah-Nouvlessounon D, N’Tcha C, et al. Antibiotic resistance and production of extended spectrum β-lactamases by clinical gram-negative bacteria in Benin. Journal of Advances in Microbiology. 2019;1:13
  98. 98. Bartley PS, Domitrovic TN, Moretto VT, Santos CS, Ponce-Terashima R, Reis MG, et al. Antibiotic resistance in Enterobacteriaceae from surface waters in urban Brazil highlights the risks of poor sanitation. The American Journal of Tropical Medicine and Hygiene. 2019;100:1369-1377
  99. 99. Ma Y, Chen J, Fong K, Nadya S, Allen K, Laing C, et al. Antibiotic resistance in Shiga toxigenic Escherichia Coli isolates from surface waters and sediments in a mixed use urban agricultural landscape. Antibiotics. 2021;10:237
  100. 100. Silva V, Ferreira E, Manageiro V, Reis L, Tejedor-Junco MT, Sampaio A, et al. Distribution and clonal diversity of Staphylococcus aureus and other staphylococci in surface waters: Detection of ST425-t742 and ST130-t843 mec C-positive MRSA strains. Antibiotics. 2021;10(11):1416
  101. 101. Samreen-Ahmad I, Malak HA, Abulreesh HH. Environmental antimicrobial resistance and its drivers: A potential threat to public health. Journal of Global Antimicrobial Resistance. 2021;27:101-111
  102. 102. Nathan C, Cars O. Antibiotic resistance—Problems, progress, and prospects. The New England Journal of Medicine. 2014;371:1761-1763
  103. 103. WHO. World Health Organization Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics. Geneva, Switzerland: WHO; 2017
  104. 104. Peacock SJ, Paterson GK. Mechanisms of methicillin resistance in Staphylococcus aureus. Annual Review of Biochemistry. 2015;84:577-601
  105. 105. Fisher JF, Mobashery S. Beta-lactam resistance mechanisms: Gram-positive bacteria and mycobacterium tuberculosis. Cold Spring Harbor Perspectives in Medicine. 2016;6:a025221
  106. 106. Muller S, Wolf AJ, Iliev ID, Berg BL, Underhill DM, Liu GY. Poorly cross-linked peptidoglycan in MRSA due to mecA induction activates the inflammasome and exacerbates immunopathology. Cell Host & Microbe. 2015;18(5):604-612. DOI: 10.1016/j.chom.2015.10.011
  107. 107. Liu J, Chen D, Peters BM, Li L, et al. Staphylococcal chromosomal cassettes mec (SCCmec): A mobile genetic element in methicillin resistant Staphylococcus aureus. Microbial Pathogenesis. 2016;101:56-67
  108. 108. Paterson GK, Harrison EM, Holmes MA. The emergence of mecC methicillin-resistant Staphylococcus aureus. Trends in Microbiology. 2014;22:42-47
  109. 109. Uhlemann AC, Otto M, Lowy FD, et al. Evolution of community and healthcare-associated methicillin-resistant Staphylococcus aureus. Infection, Genetics and Evolution. 2014;21:563-574
  110. 110. Porrero MC, Valverde A, Fernandez-Llario P, Diez-Guerrier A, Mateos A, Lavin S, et al. Staphylococcus aureus carrying mecC gene in animals and urban wastewater, Spain. Emerging Infectious Diseases. 2014;20(5):899-901. DOI: 10.3201/eid2005.130426
  111. 111. Wan MT, Chou CC. Spreading of beta-lactam resistance gene (mecA) and methicillin resistant Staphylococcus aureus through municipal and swine slaughterhouse wastewaters. Water Research. 2014;64:288-295. DOI: 10.1016/j.watres.2014.07.014
  112. 112. Brooks JP, Adeli A, McLaughlin MR. Microbial ecology, bacterial pathogens, and antibiotic resistant genes in swine manure wastewater as influenced by three swine management systems. Water Research. 2014;57:96-103. DOI: 10.1016/j.watres.2014.03.017
  113. 113. Edokpayi JN, Rogawski ET, Kahler DM, Hill CL, Reynolds C, Nyathi E, et al. Challenges to sustainable safe drinking water: A case study of water quality and use across seasons in rural communities in Limpopo Province, South Africa. Water. 2018;10:159
  114. 114. Amarasiri M, Sano D, Suzuki S. Understanding human health risks caused by antibiotic resistant bacteria (ARB) and antibiotic resistance genes (ARG) in water environments: Current knowledge and questions to be answered. Critical Reviews in Environmental Science and Technology. 2019:1-44
  115. 115. World Health Organization (WHO). Global Action Plan on Antimicrobial Resistance. Geneva, Switzerland: WHO; 2015. pp. 1-19
  116. 116. Domingo-Echaburu S, Dávalos LM, Orive G, Lertxundi U. Drug pollution and sustainable development goals. Science of the Total Environment. 2021;800:149412
  117. 117. Kookana RS, Drechsel P, Jamwal P, Vanderzalm J. Urbanisation and emerging economies: Issues and potential solutions for water and food security. Science of the Total Environment. 2020;732:139057

Written By

Abimbola Olumide Adekanmbi, Ridwan Olamilekan Adesola, Adedoyin Olutoyin Adeyemi and Chisom Chinyere Mbionwu

Submitted: 18 September 2023 Reviewed: 20 November 2023 Published: 20 December 2023